Hospital Lluís Alcanyís, Xàtiva, Spain.
Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Acta Ophthalmol. 2022 Dec;100(8):878-893. doi: 10.1111/aos.15160. Epub 2022 May 9.
Systematic reviews (SRs) and meta-analyses (MAs) are of great importance for basing clinical decisions. However, misleading interpretations may result when informed decisions rest on biased review papers with methodological issues. To evaluate which treatment is optimal, an overview was made of SRs and MAs to establish the quality and certainty of meta-evidence published on the efficacy of laser-based refractive surgery techniques for treating myopia in adults. A search was made in five databases and was updated using Really Simple Syndication (RSS) feed appliances up to April 2021; SRs with or without MAs were included. Methodological quality was appraised using the AMSTAR-2 tool. The best available reviews were summarized using the GRADE approach. The corrected covered area (CCA) was used to determine the degree of over-representation of publications. The risk of bias of the primary studies was disclosed visually. Thirty-six studies published between 2003 and 2021 were included. Twenty SRs (56%) were conducted in China. The most studied comparisons were SMILE versus FS-LASIK (19%) and FS-LASIK versus MM-LASIK (11%). Of the 251 overlapping index publications, 165 were unique (CCA = 0.015%), representing a negligible risk of skewed reporting. The AMSTAR-2 tool showed most SRs to have critically low or low quality. Nine reviews presented moderate quality. The GRADE approach of the 41 a priori outcomes evidenced critically low and low certainty of evidence. Only the spherical equivalent refraction changes at 12 months between LASEK and PRK showed moderate certainty of evidence, favouring PRK (mean difference 0.06, 95%CI [-0.02 to 0.14], I = 0%; p ≥ 0.05). Index trials among less biased reviews are prone to selection, performance and reporting bias. The appraised techniques exhibit comparable results in terms of efficacy. There is moderate certainty of evidence in favour of the use of PRK over LASEK in terms of the spherical equivalent refraction error changes at 1 year of follow-up. Most appraised SRs presented methodological flaws in critical domains, resulting in a low to critically low certainty of evidence after GRADE appraisal. Therefore, investigators need to study and compare the different laser-based refractive techniques to provide better evidence-based medicine. Further well-designed, high-quality clinical trials and SRs are needed to reappraise the current findings.
系统评价(SRs)和荟萃分析(MAs)对于基于临床决策非常重要。然而,当基于具有方法学问题的有偏见的综述论文做出明智的决策时,可能会产生误导性的解释。为了评估哪种治疗方法是最佳的,我们对 SRs 和 MAs 进行了综述,以确定已发表的关于激光屈光手术技术治疗成年人近视疗效的元证据的质量和确定性。我们在五个数据库中进行了检索,并使用 Really Simple Syndication(RSS)订阅工具进行了更新,截至 2021 年 4 月;包括有或没有 MA 的 SRs。使用 AMSTAR-2 工具评估方法学质量。使用 GRADE 方法总结最佳现有综述。使用校正覆盖面积(CCA)来确定出版物过度代表的程度。公开了主要研究的偏倚风险。纳入了 2003 年至 2021 年期间发表的 36 项研究。20 项 SRs(56%)在中国进行。研究最多的比较是 SMILE 与 FS-LASIK(19%)和 FS-LASIK 与 MM-LASIK(11%)。在 251 篇重叠索引出版物中,有 165 篇是独一无二的(CCA=0.015%),表明报告存在偏差的风险可以忽略不计。AMSTAR-2 工具显示大多数 SRs 的质量为临界低或低。9 项综述的质量为中度。41 个先验结果的 GRADE 方法表明证据的确定性为临界低和低。只有 LASEK 和 PRK 之间 12 个月的等效球镜屈光度变化具有中度确定性的证据,有利于 PRK(平均差异 0.06,95%CI [-0.02 至 0.14],I=0%;p≥0.05)。在评价较低偏倚的综述中,索引试验更容易受到选择、表现和报告偏倚的影响。评估的技术在疗效方面表现出相当的结果。在 1 年随访时等效球镜屈光度误差变化方面,有中度确定性的证据支持使用 PRK 而不是 LASEK。经过 GRADE 评价后,大多数评价的 SRs 在关键领域都存在方法学缺陷,导致证据的确定性为低至临界低。因此,研究人员需要研究和比较不同的基于激光的屈光技术,以提供更好的循证医学。需要进一步设计良好、高质量的临床试验和 SRs 来重新评估当前的发现。